WuXi AppTec (OTCMKTS:WUXAY) Stock Price Down 7% – What’s Next?

Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) dropped 7% on Friday . The stock traded as low as $19.53 and last traded at $19.53. 144 shares changed hands during trading, a decline of 93% from the average daily volume of 2,174 shares. The stock had previously closed at $21.00.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy”.

WuXi AppTec Stock Performance

The stock has a 50-day moving average of $17.42 and a 200-day moving average of $15.81.

WuXi AppTec (OTCMKTS:WUXAY) last posted its earnings results on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.